MedVentures' half-day virtual conference, organized by Dallas-based accelerator Health Wildcatters, kicked off the Polsinelli Healthcare Dealmakers Conference.

Two dozen North Texas startups hauled in millions of dollars in the first quarter of 2020.

The company founded in 2013 has drugs in clinical trial for prostate and lung cancers.

Hubert Zajicek wants to tap the strong innovation community in North Texas to share know-how, combat shortages, and come up with new solutions during the COVID-19 pandemic.

Dallas-Fort Worth's strength in diverse industry hotspots such as fintech, AI, and life sciences make it a seedbed for billion-dollar players to emerge.

Health Wildcatters' third hackathon—the first focused on women—hosted more than 100 female innovators and entrepreneurs to create actionable solutions for problems in healthcare and life sciences.

Among the contributions of recipient Paul Dorman, the chairman and CEO of DFB Pharmaceuticals, is paying for the first-year tuition of the entire inaugural class of M.D. students at the TCU and UNTHSC School of Medicine in Fort Worth.

This diverse group of founders has two things in common: joining Health Wildcatters and getting stuck in an elevator.

The Texas Healthcare Challenge gives healthcare consumers the opportunity to find new innovations to systems that might be broken. After the teams went head-to-head with their solutions, a total prize package valued at more than $360K was awarded.

The team's virtual reality simulation places novice surgeons inside a surgical theater in Zambia to learn the intricacies of performing a hysterectomy to battle cervical cancer.

The women’s sexuality and wellness platform beat nine competitors to take the top prize in the pitch competition that was part of the Healthcare Dealmakers Conference in Dallas.